Our prospective study design, evaluation of baseline and follow-up measures, extensive control for potential confounders, and utilization of objective measures of AF-ALB and CD4 counts provide compelling evidence for a strong epidemiologic association that deserves careful attention. The gene discussed is ALB; the disease is atrial fibrillation.